Lite Strategy Inc (LITS)

$1.11 +0.05 (4.72%)
Market Cap 37.77M
Revenue (ttm) 0.00
Net Income (ttm) -15.95M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 278,100
Avg Vol 207,902
Day's Range N/A - N/A
Shares Out 34.03M
Stochastic %K 79%
Beta 0.21
Analysts Hold
Price Target N/A

Company Profile

Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.

Industry: Biotechnology
Sector: Healthcare
Phone: 858 369 7100
Address:
9920 Pacific Heights Blvd., Suite 150, San Diego, United States
cmnorman
cmnorman Sep. 13 at 5:34 PM
$LITS Things are gonna get interesting here. 👀
0 · Reply
topstockalerts
topstockalerts Sep. 7 at 9:04 PM
$LITS this might sneak up on people if it keeps going
0 · Reply
rac0258
rac0258 Sep. 4 at 9:31 PM
$LTC.X If you love Litecoin- be sure to look over what it going on in our partnerships, not just @LitVM but also $LTCC $LUXFF and $LITS
0 · Reply
R3JS
R3JS Sep. 4 at 8:09 PM
$LITS $LTC.X 15% week 😮‍💨daily buy signal weekly buy signal monthly buy signal and quarterly buy signal. There hasn’t been a 4HR golden cross all year on LITS but should come next week!
0 · Reply
R3JS
R3JS Sep. 4 at 5:05 PM
$LTC.X $LITS LITS is doing well today and so close to running 🏃 bull markets give it a premium instead of a discount so it leveling out and getting rid of the discount would be a very bullish sign.
0 · Reply
Leogolas
Leogolas Sep. 3 at 7:49 PM
$LITS
0 · Reply
R3JS
R3JS Sep. 3 at 4:02 PM
$LTC.X $LITS 1Million volume LITs!!
0 · Reply
R3JS
R3JS Sep. 3 at 3:00 PM
$LTC.X can you fill the sizzle $LITS 5x options volume being placed right now
0 · Reply
R3JS
R3JS Sep. 3 at 1:17 AM
$LTC.X $LITS big day for LIts tomorrow it’s at the edge of breaking its channel with daily weekly and quarterly buy signals 🤯🧨🚀
0 · Reply
R3JS
R3JS Aug. 31 at 6:48 PM
$LTC.X $LITS has been creating 30 plus days of support on the 50MA!! If that’s not creating a bullit proof vest then what is!?!?!
0 · Reply
Latest News on LITS
Lite Strategy to Present at the 28th Annual H.C. Wainwright Global Investment Conference in New York

Sep 10, 2026, 9:00 AM EDT - 3 days ago

Lite Strategy to Present at the 28th Annual H.C. Wainwright Global Investment Conference in New York

Lite Strategy Repurchases 13% of Outstanding Shares Since December, Increasing Litecoin Backing Per Share

Jul 30, 2026, 8:30 AM EDT - 6 weeks ago

Lite Strategy Repurchases 13% of Outstanding Shares Since December, Increasing Litecoin Backing Per Share

Lite Strategy Slides: Investor presentation

Jul 25, 2026, 9:00 AM EDT - 7 weeks ago

Lite Strategy Slides: Investor presentation

Lite Strategy to Attend Panel at Litecoin Foundation Summit in Amsterdam

Jun 19, 2026, 8:30 AM EDT - 2 months ago

Lite Strategy to Attend Panel at Litecoin Foundation Summit in Amsterdam

LTC

Lite Strategy leads strategic investment in LitVM

2026-06-18T12:48:16.000Z - 2 months ago

Lite Strategy leads strategic investment in LitVM

Lite Strategy Leads Strategic Investment in LitVM

Jun 18, 2026, 8:30 AM EDT - 2 months ago

Lite Strategy Leads Strategic Investment in LitVM

Lite Strategy Reports Fiscal 2026 Third Quarter Results

May 13, 2026, 8:30 AM EDT - 4 months ago

Lite Strategy Reports Fiscal 2026 Third Quarter Results

Lite Strategy Quarterly report: Q3 2026

May 13, 2026, 7:00 AM EDT - 4 months ago

Lite Strategy Quarterly report: Q3 2026

Lite Strategy Earnings release: Q3 2026

May 13, 2026, 7:00 AM EDT - 4 months ago

Lite Strategy Earnings release: Q3 2026

Lite Strategy reports Q2 EPS (82c) vs. (40c) last year

2026-02-17T14:40:22.000Z - 6 months ago

Lite Strategy reports Q2 EPS (82c) vs. (40c) last year

Lite Strategy to continue to evaluate strategic investments in 2H of 2026

2026-02-17T14:00:57.000Z - 6 months ago

Lite Strategy to continue to evaluate strategic investments in 2H of 2026

Lite Strategy Reports Fiscal 2026 Second Quarter Results

Feb 17, 2026, 8:50 AM EST - 6 months ago

Lite Strategy Reports Fiscal 2026 Second Quarter Results

Lite Strategy Earnings release: Q2 2026

Feb 17, 2026, 7:00 AM EST - 6 months ago

Lite Strategy Earnings release: Q2 2026

Lite Strategy Quarterly report: Q2 2026

Feb 17, 2026, 7:00 AM EST - 6 months ago

Lite Strategy Quarterly report: Q2 2026

Lite Strategy Proxy statement: Proxy Filing

Jan 27, 2026, 7:00 AM EST - 7 months ago

Lite Strategy Proxy statement: Proxy Filing

Lite Strategy Proxy statement: Proxy Filing

Dec 30, 2025, 7:00 AM EST - 8 months ago

Lite Strategy Proxy statement: Proxy Filing

Lite Strategy Proxy statement: Proxy Filing

Dec 30, 2025, 7:00 AM EST - 8 months ago

Lite Strategy Proxy statement: Proxy Filing

Lite Strategy names acting CEO Justin File to role on a permanent basis

2025-11-19T16:15:44.000Z - 9 months ago

Lite Strategy names acting CEO Justin File to role on a permanent basis

Lite Strategy reports Q1 results, highlights launch of $100M Litecoin Treasury

2025-11-17T14:05:45.000Z - 10 months ago

Lite Strategy reports Q1 results, highlights launch of $100M Litecoin Treasury

Lite Strategy Quarterly report: Q1 2026

Nov 14, 2025, 4:00 PM EST - 10 months ago

Lite Strategy Quarterly report: Q1 2026

Lite Strategy announces $25M share repurchase program

2025-10-29T13:12:45.000Z - 10 months ago

Lite Strategy announces $25M share repurchase program

Lite Strategy files to sell 780,497 shares of common stock for holders

2025-10-08T20:50:10.000Z - 11 months ago

Lite Strategy files to sell 780,497 shares of common stock for holders

Lite Strategy Registration statement: Registration Filing

Oct 8, 2025, 8:00 AM EDT - 11 months ago

Lite Strategy Registration statement: Registration Filing

Lite Strategy Annual report: Q4 2025

Sep 26, 2025, 7:00 AM EDT - 11 months ago

Lite Strategy Annual report: Q4 2025

MEI Pharma, Inc. Rebrands as Lite Strategy, Inc., Adopts New NASDAQ Ticker ‘LITS'

Sep 10, 2025, 9:00 AM EDT - 1 year ago

MEI Pharma, Inc. Rebrands as Lite Strategy, Inc., Adopts New NASDAQ Ticker ‘LITS'

Lite Strategy Registration statement: Registration Filing

Aug 26, 2025, 8:00 AM EDT - 1 year ago

Lite Strategy Registration statement: Registration Filing

Lite Strategy Registration statement: Registration Filing

Aug 6, 2025, 8:00 AM EDT - 1 year ago

Lite Strategy Registration statement: Registration Filing

MEI Pharma Acquires Litecoin, Launches $100M Institutional Treasury Strategy with Charlie Lee and GSR Advising

Aug 5, 2025, 8:00 AM EDT - 1 year ago

MEI Pharma Acquires Litecoin, Launches $100M Institutional Treasury Strategy with Charlie Lee and GSR Advising

BTC digital asset field continues to exert its strength, HASHJ launches Bitcoin cloud mining platform with "capital + technology" dual-driven mode

Jul 24, 2025, 8:00 PM EDT - 1 year ago

BTC digital asset field continues to exert its strength, HASHJ launches Bitcoin cloud mining platform with "capital + technology" dual-driven mode

MEI Pharma Announces Closing of $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange

Jul 22, 2025, 4:35 PM EDT - 1 year ago

MEI Pharma Announces Closing of $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange

MEI Pharma Announces $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange

Jul 18, 2025, 8:30 AM EDT - 1 year ago

MEI Pharma Announces $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange

MEI Pharma Reports Third Quarter Fiscal Year 2025 Cash Position

May 13, 2025, 4:05 PM EDT - 1 year ago

MEI Pharma Reports Third Quarter Fiscal Year 2025 Cash Position

Lite Strategy Earnings release: Q3 2025

May 13, 2025, 4:00 PM EDT - 1 year ago

Lite Strategy Earnings release: Q3 2025

Lite Strategy Quarterly report: Q3 2025

May 13, 2025, 4:00 PM EDT - 1 year ago

Lite Strategy Quarterly report: Q3 2025

MEI Pharma Reports Second Quarter Fiscal Year 2025 Cash Position

Feb 12, 2025, 4:12 PM EST - 1 year ago

MEI Pharma Reports Second Quarter Fiscal Year 2025 Cash Position

Lite Strategy Earnings release: Q2 2025

Feb 12, 2025, 12:00 AM EST - 1 year ago

Lite Strategy Earnings release: Q2 2025

Lite Strategy Quarterly report: Q2 2025

Feb 12, 2025, 12:00 AM EST - 1 year ago

Lite Strategy Quarterly report: Q2 2025

Lite Strategy Proxy statement: Proxy Filing

Dec 20, 2024, 7:00 AM EST - 1 year ago

Lite Strategy Proxy statement: Proxy Filing

Lite Strategy Proxy statement: Proxy Filing

Dec 20, 2024, 7:00 AM EST - 1 year ago

Lite Strategy Proxy statement: Proxy Filing

MEI Pharma Reports First Quarter Fiscal Year 2025 Cash Position

Nov 12, 2024, 4:05 PM EST - 1 year ago

MEI Pharma Reports First Quarter Fiscal Year 2025 Cash Position

Lite Strategy Earnings release: Q1 2025

Nov 12, 2024, 4:00 PM EST - 1 year ago

Lite Strategy Earnings release: Q1 2025

Lite Strategy Quarterly report: Q1 2025

Nov 12, 2024, 4:00 PM EST - 1 year ago

Lite Strategy Quarterly report: Q1 2025

MEI Pharma Reports Fiscal Year End 2024 Cash Position

Sep 19, 2024, 4:01 PM EDT - 1 year ago

MEI Pharma Reports Fiscal Year End 2024 Cash Position

Lite Strategy Earnings release: Q4 2024

Sep 18, 2024, 6:00 PM EDT - 1 year ago

Lite Strategy Earnings release: Q4 2024

Lite Strategy Annual report: Q4 2024

Sep 18, 2024, 6:00 PM EDT - 1 year ago

Lite Strategy Annual report: Q4 2024

MEI Pharma Engages Oppenheimer & Co. Inc. to Assist in Evaluating Strategic Alternatives

Aug 12, 2024, 8:30 AM EDT - 2 years ago

MEI Pharma Engages Oppenheimer & Co. Inc. to Assist in Evaluating Strategic Alternatives

MEI Pharma to Consider Strategic Alternatives

Jul 22, 2024, 8:30 AM EDT - 2 years ago

MEI Pharma to Consider Strategic Alternatives

MEI Pharma Reports Third Quarter Fiscal Year 2024 Results and Operational Highlights

May 9, 2024, 4:02 PM EDT - 2 years ago

MEI Pharma Reports Third Quarter Fiscal Year 2024 Results and Operational Highlights

Lite Strategy Quarterly report: Q3 2024

May 9, 2024, 4:00 PM EDT - 2 years ago

Lite Strategy Quarterly report: Q3 2024

Lite Strategy Earnings release: Q3 2024

May 9, 2024, 4:00 PM EDT - 2 years ago

Lite Strategy Earnings release: Q3 2024

Lite Strategy Transcript: Stifel Virtual Targeted Oncology Days Conference

Apr 16, 2024, 1:30 PM EDT - 2 years ago

Lite Strategy Transcript: Stifel Virtual Targeted Oncology Days Conference

MEI Pharma Board of Directors Aligns on Strategy to Advance Voruciclib and ME-344

Apr 11, 2024, 8:02 AM EDT - 2 years ago

MEI Pharma Board of Directors Aligns on Strategy to Advance Voruciclib and ME-344

MEI Pharma Reports Initial Data from Clinical Study Evaluating ME-344 in Combination with Bevacizumab (Avastin®) in Relapsed Metastatic Colorectal Cancer Patients

Apr 11, 2024, 8:00 AM EDT - 2 years ago

MEI Pharma Reports Initial Data from Clinical Study Evaluating ME-344 in Combination with Bevacizumab (Avastin®) in Relapsed Metastatic Colorectal Cancer Patients

MEI Pharma to Present at the Stifel 2024 Virtual Targeted Oncology Forum

Apr 10, 2024, 8:00 AM EDT - 2 years ago

MEI Pharma to Present at the Stifel 2024 Virtual Targeted Oncology Forum

MEI Pharma Reports Update from Clinical Study Evaluating Oral CDK9 Inhibitor Voruciclib in Combination with Venetoclax in Patients with Relapsed and Refractory Acute Myeloid Leukemia

Mar 26, 2024, 8:00 AM EDT - 2 years ago

MEI Pharma Reports Update from Clinical Study Evaluating Oral CDK9 Inhibitor Voruciclib in Combination with Venetoclax in Patients with Relapsed and Refractory Acute Myeloid Leukemia

Lite Strategy Registration statement: Registration Filing

Feb 20, 2024, 7:00 AM EST - 2 years ago

Lite Strategy Registration statement: Registration Filing

MEI Pharma Reports Second Quarter Fiscal Year 2024 Results and Operational Highlights

Feb 13, 2024, 5:05 PM EST - 2 years ago

MEI Pharma Reports Second Quarter Fiscal Year 2024 Results and Operational Highlights

Lite Strategy Quarterly report: Q2 2024

Feb 13, 2024, 4:00 PM EST - 2 years ago

Lite Strategy Quarterly report: Q2 2024

Lite Strategy Earnings release: Q2 2024

Feb 13, 2024, 4:00 PM EST - 2 years ago

Lite Strategy Earnings release: Q2 2024

MEI Pharma to Present Design of Ongoing Clinical Study Evaluating ME-344 at ASCO GI Cancers Symposium 2024

Jan 16, 2024, 5:00 PM EST - 2 years ago

MEI Pharma to Present Design of Ongoing Clinical Study Evaluating ME-344 at ASCO GI Cancers Symposium 2024

MEI Pharma Reports Clinical Data on Oral CDK9 Inhibitor Voruciclib at ASH2023

Dec 11, 2023, 12:00 PM EST - 2 years ago

MEI Pharma Reports Clinical Data on Oral CDK9 Inhibitor Voruciclib at ASH2023

Lite Strategy Transcript: The Stifel 2023 Annual Healthcare Conference

Nov 15, 2023, 8:35 AM EST - 2 years ago

Lite Strategy Transcript: The Stifel 2023 Annual Healthcare Conference

MEI Pharma Reports First Quarter Fiscal Year 2024 Results and Operational Highlights

Nov 9, 2023, 4:05 PM EST - 2 years ago

MEI Pharma Reports First Quarter Fiscal Year 2024 Results and Operational Highlights

Lite Strategy Quarterly report: Q1 2024

Nov 9, 2023, 4:00 PM EST - 2 years ago

Lite Strategy Quarterly report: Q1 2024

Lite Strategy Earnings release: Q1 2024

Nov 9, 2023, 4:00 PM EST - 2 years ago

Lite Strategy Earnings release: Q1 2024

MEI Pharma to Present at the Stifel 2023 Healthcare Conference

Nov 8, 2023, 8:00 AM EST - 2 years ago

MEI Pharma to Present at the Stifel 2023 Healthcare Conference

Lite Strategy Proxy statement: Proxy Filing

Nov 8, 2023, 7:00 AM EST - 2 years ago

Lite Strategy Proxy statement: Proxy Filing

Lite Strategy Proxy statement: Proxy Filing

Nov 8, 2023, 7:00 AM EST - 2 years ago

Lite Strategy Proxy statement: Proxy Filing

MEI Pharma Declares Special Cash Dividend of $1.75 Per Share of Common Stock

Nov 6, 2023, 4:57 PM EST - 2 years ago

MEI Pharma Declares Special Cash Dividend of $1.75 Per Share of Common Stock

MEI Pharma Announces Acceptance of Abstract for Presentation at ASH 2023

Nov 2, 2023, 9:00 AM EDT - 2 years ago

MEI Pharma Announces Acceptance of Abstract for Presentation at ASH 2023

MEI Pharma Enters into Agreement with Anson Funds and Cable Car Capital

Nov 1, 2023, 9:00 AM EDT - 2 years ago

MEI Pharma Enters into Agreement with Anson Funds and Cable Car Capital

Lite Strategy Proxy statement: Proxy Filing

Nov 1, 2023, 8:00 AM EDT - 2 years ago

Lite Strategy Proxy statement: Proxy Filing

Lite Strategy Proxy statement: Proxy Filing

Oct 18, 2023, 8:00 AM EDT - 2 years ago

Lite Strategy Proxy statement: Proxy Filing

MEI Pharma Recommends Stockholders Not to Consent

Oct 17, 2023, 5:33 PM EDT - 2 years ago

MEI Pharma Recommends Stockholders Not to Consent

Lite Strategy Proxy statement: Proxy Filing

Oct 17, 2023, 8:00 AM EDT - 2 years ago

Lite Strategy Proxy statement: Proxy Filing

Lite Strategy Proxy statement: Proxy Filing

Oct 12, 2023, 8:00 AM EDT - 2 years ago

Lite Strategy Proxy statement: Proxy Filing

Lite Strategy Proxy statement: Proxy Filing

Oct 10, 2023, 8:00 AM EDT - 2 years ago

Lite Strategy Proxy statement: Proxy Filing

Lite Strategy Proxy statement: Proxy Filing

Oct 2, 2023, 8:00 AM EDT - 2 years ago

Lite Strategy Proxy statement: Proxy Filing

MEI Pharma Adopts Limited-Duration Stockholder Rights Plan

Oct 2, 2023, 6:00 AM EDT - 2 years ago

MEI Pharma Adopts Limited-Duration Stockholder Rights Plan

Lite Strategy Proxy statement: Proxy Filing

Sep 29, 2023, 8:00 AM EDT - 2 years ago

Lite Strategy Proxy statement: Proxy Filing

MEI Pharma Issues Statement Regarding Anson and Cable Car's Opportunistic Actions

Sep 28, 2023, 5:00 PM EDT - 2 years ago

MEI Pharma Issues Statement Regarding Anson and Cable Car's Opportunistic Actions

Lite Strategy Proxy statement: Proxy Filing

Sep 28, 2023, 8:00 AM EDT - 2 years ago

Lite Strategy Proxy statement: Proxy Filing

Lite Strategy Proxy statement: Proxy Filing

Sep 28, 2023, 8:00 AM EDT - 2 years ago

Lite Strategy Proxy statement: Proxy Filing

Lite Strategy Earnings Call Transcript: Q4 2023

Sep 26, 2023, 5:00 PM EDT - 2 years ago

Lite Strategy Earnings Call Transcript: Q4 2023

Lite Strategy Annual report: Q4 2023

Sep 26, 2023, 5:00 PM EDT - 2 years ago

Lite Strategy Annual report: Q4 2023

Lite Strategy Earnings release: Q4 2023

Sep 26, 2023, 5:00 PM EDT - 2 years ago

Lite Strategy Earnings release: Q4 2023

MEI Pharma Reports Fiscal Year 2023 Results and Operational Highlights

Sep 26, 2023, 4:02 PM EDT - 2 years ago

MEI Pharma Reports Fiscal Year 2023 Results and Operational Highlights

Lite Strategy Proxy statement: Proxy Filing

Sep 26, 2023, 8:00 AM EDT - 2 years ago

Lite Strategy Proxy statement: Proxy Filing

MEI Pharma to Report 2023 Fiscal Year End Financial Results and Provide Corporate Overview on September 26, 2023

Sep 21, 2023, 8:00 AM EDT - 2 years ago

MEI Pharma to Report 2023 Fiscal Year End Financial Results and Provide Corporate Overview on September 26, 2023

MEI Pharma Confirms Receipt of Director Nominations From Anson and Cable Car

Sep 18, 2023, 8:00 AM EDT - 2 years ago

MEI Pharma Confirms Receipt of Director Nominations From Anson and Cable Car

Lite Strategy Proxy statement: Proxy Filing

Sep 18, 2023, 8:00 AM EDT - 2 years ago

Lite Strategy Proxy statement: Proxy Filing

Lite Strategy Proxy statement: Proxy Filing

Sep 15, 2023, 8:00 AM EDT - 2 years ago

Lite Strategy Proxy statement: Proxy Filing

MEI Pharma Announces First Patient Dosed in Clinical Study Evaluating ME-344 Plus Bevacizumab (AVASTIN®) in Patients with Previously Treated Metastatic Colorectal Cancer

Aug 16, 2023, 8:00 AM EDT - 3 years ago

MEI Pharma Announces First Patient Dosed in Clinical Study Evaluating ME-344 Plus Bevacizumab (AVASTIN®) in Patients with Previously Treated Metastatic Colorectal Cancer

MEI Pharma Announces Results of Special Meeting of Stockholders

Jul 23, 2023, 2:30 PM EDT - 3 years ago

MEI Pharma Announces Results of Special Meeting of Stockholders

MEI Pharma Reminds Shareholders to Vote Today FOR the Infinity Transaction

Jul 19, 2023, 8:00 AM EDT - 3 years ago

MEI Pharma Reminds Shareholders to Vote Today FOR the Infinity Transaction

MEI Pharma Responds to Anson and Cable Car

Jul 18, 2023, 9:00 AM EDT - 3 years ago

MEI Pharma Responds to Anson and Cable Car

MEI Pharma Encourages Shareholders to Vote FOR the Infinity Transaction

Jul 17, 2023, 8:00 AM EDT - 3 years ago

MEI Pharma Encourages Shareholders to Vote FOR the Infinity Transaction

Lite Strategy Proxy statement: Proxy Filing

Jul 17, 2023, 8:00 AM EDT - 3 years ago

Lite Strategy Proxy statement: Proxy Filing

MEI Pharma Postpones Special Meeting of Shareholders

Jul 13, 2023, 4:05 PM EDT - 3 years ago

MEI Pharma Postpones Special Meeting of Shareholders

MEI Pharma Provides Final Reminder to Shareholders to Vote Today FOR the Merger With Infinity Pharmaceuticals

Jul 11, 2023, 8:00 AM EDT - 3 years ago

MEI Pharma Provides Final Reminder to Shareholders to Vote Today FOR the Merger With Infinity Pharmaceuticals

MEI Pharma Reminds Shareholders to Vote FOR the Merger with Infinity Pharmaceuticals

Jul 7, 2023, 8:00 AM EDT - 3 years ago

MEI Pharma Reminds Shareholders to Vote FOR the Merger with Infinity Pharmaceuticals

ISS Recommends Infinity Pharmaceuticals Stockholders Vote FOR the Merger with MEI Pharma, Inc.

Jul 5, 2023, 8:30 AM EDT - 3 years ago

ISS Recommends Infinity Pharmaceuticals Stockholders Vote FOR the Merger with MEI Pharma, Inc.

MEI Pharma Highlights Recommendation by Leading Independent Proxy Advisory Firm ISS to Vote “FOR” Pending Transaction with Infinity Pharmaceuticals

Jul 5, 2023, 8:00 AM EDT - 3 years ago

MEI Pharma Highlights Recommendation by Leading Independent Proxy Advisory Firm ISS to Vote “FOR” Pending Transaction with Infinity Pharmaceuticals

MEI Pharma Mails Letter to Shareholders Reiterating Value Creating Potential of Proposed Transaction with Infinity Pharmaceuticals

Jun 29, 2023, 8:00 AM EDT - 3 years ago

MEI Pharma Mails Letter to Shareholders Reiterating Value Creating Potential of Proposed Transaction with Infinity Pharmaceuticals

MEI Pharma and Infinity Pharmaceuticals Host Video Webcast Providing Overview and Update on Pending Merger to Advance Three Promising Clinical Oncology Candidates

Jun 15, 2023, 12:08 PM EDT - 3 years ago

MEI Pharma and Infinity Pharmaceuticals Host Video Webcast Providing Overview and Update on Pending Merger to Advance Three Promising Clinical Oncology Candidates

INFINITY PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Infinity Pharmaceuticals, Inc. - INFI

Jun 14, 2023, 7:01 PM EDT - 3 years ago

INFINITY PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Infinity Pharmaceuticals, Inc. - INFI

cmnorman
cmnorman Sep. 13 at 5:34 PM
$LITS Things are gonna get interesting here. 👀
0 · Reply
topstockalerts
topstockalerts Sep. 7 at 9:04 PM
$LITS this might sneak up on people if it keeps going
0 · Reply
rac0258
rac0258 Sep. 4 at 9:31 PM
$LTC.X If you love Litecoin- be sure to look over what it going on in our partnerships, not just @LitVM but also $LTCC $LUXFF and $LITS
0 · Reply
R3JS
R3JS Sep. 4 at 8:09 PM
$LITS $LTC.X 15% week 😮‍💨daily buy signal weekly buy signal monthly buy signal and quarterly buy signal. There hasn’t been a 4HR golden cross all year on LITS but should come next week!
0 · Reply
R3JS
R3JS Sep. 4 at 5:05 PM
$LTC.X $LITS LITS is doing well today and so close to running 🏃 bull markets give it a premium instead of a discount so it leveling out and getting rid of the discount would be a very bullish sign.
0 · Reply
Leogolas
Leogolas Sep. 3 at 7:49 PM
$LITS
0 · Reply
R3JS
R3JS Sep. 3 at 4:02 PM
$LTC.X $LITS 1Million volume LITs!!
0 · Reply
R3JS
R3JS Sep. 3 at 3:00 PM
$LTC.X can you fill the sizzle $LITS 5x options volume being placed right now
0 · Reply
R3JS
R3JS Sep. 3 at 1:17 AM
$LTC.X $LITS big day for LIts tomorrow it’s at the edge of breaking its channel with daily weekly and quarterly buy signals 🤯🧨🚀
0 · Reply
R3JS
R3JS Aug. 31 at 6:48 PM
$LTC.X $LITS has been creating 30 plus days of support on the 50MA!! If that’s not creating a bullit proof vest then what is!?!?!
0 · Reply
MVISShortSellersLost
MVISShortSellersLost Aug. 28 at 9:16 PM
$LITS $LTC.X $MVIS You surely are troubling p*ss poor influencers by buying more
1 · Reply
R3JS
R3JS Aug. 28 at 7:05 PM
$LTC.X bought more $LITS and $MVIS today
0 · Reply
R3JS
R3JS Aug. 27 at 3:08 PM
$LTC.X $LITS if lits breaks this channel it’s over it looks like risk on assets are here for the first time since 2020
0 · Reply
rac0258
rac0258 Aug. 27 at 2:03 PM
$LTC.X $LITS $LUXFF $LTCN Congratulations Luxxfolio for the mining expansion. @LuxxfolioH has expanded their Litecoin mining to 228 @BITMAINtech Scrypt machines up from the original 60.
1 · Reply
rac0258
rac0258 Aug. 26 at 5:24 PM
$LTC.X $LITS Really great interview from Miss Teen Crypto and Jay the CEO and CFO of LiteStrategy. He’s focused on what we’ve built now, and also as we round the corner to the end of the year- there will be some very positive developments worth holding on for. https://youtu.be/ItXOfFFHjQg
1 · Reply
R3JS
R3JS Aug. 26 at 4:50 PM
$LITS bottom of its bullish channel this it the make or break on the squeeze. I’m locked and loaded for the long haul either way
0 · Reply
rac0258
rac0258 Aug. 26 at 3:39 PM
$LITS Bought more.
0 · Reply
R3JS
R3JS Aug. 24 at 7:00 PM
$LTC.X $LITS has a weekly and quarterly buy signal but the quarter needs to hold by Sept 30th. Minus a rug pull it looks like it’s time to get rich 🤑
0 · Reply
R3JS
R3JS Aug. 24 at 4:08 PM
$LTC.X $LITS lits breaks here it’s game on
0 · Reply
gerbens
gerbens Aug. 24 at 2:27 PM
$LITS huge discount to nav, expect more share buybacks at this price
0 · Reply
R3JS
R3JS Aug. 23 at 11:51 PM
$LTC.X $LITS channel is painting the bottom for far too long for $LITS
0 · Reply
R3JS
R3JS Aug. 23 at 2:34 PM
$LTC.X if you are mad you missed $39 guess what you can still buy at $39 it’s called $LITS and it equates out to exactly $39 and they are driven to only equal the exact price of Litecoin at all times. I’m sure it will be up Monday but kinda crazy you can still buy at $39 or close.
0 · Reply